Inhibition of hamster buccal pouch carcinogenesis by limonin 17-beta-D-glucopyranoside. 1992

E G Miller, and A P Gonzales-Sanders, and A M Couvillon, and J M Wright, and S Hasegawa, and L K Lam
Department of Biochemistry, Baylor College of Dentistry, Dallas, TX 75246.

Limonin 17-beta-D-glucopyranoside, nomilin 17-beta-D-glucopyranoside, and nomilinic acid 17-beta-D-glucopyranoside, three limonoid glucosides isolated from oranges, were tested for cancer chemopreventive activity. Eighty female Syrian hamsters were divided into four equal groups. The left buccal pouches of the animals in each group were pretreated topically with two applications of water (Group I) or a 3.5% solution of limonin 17-beta-D-glucopyranoside (Group II), nomilin 17-beta-D-glucopyranoside (Group III), or nomilinic acid 17-beta-D-glucopyranoside (Group IV). After this initial treatment, the left buccal pouches of 16 hamsters from each group were painted five times per week. Two or three times per week the pouches were treated with a 0.5% solution of the carcinogen 7,12-di-methylbenz[a]anthracene (DMBA) dissolved in mineral oil. On alternate days, the pouches were treated with water (Group I) or a 3.5% solution of limonin 17-beta-D-glucopyranoside (Group II), nomilin 17-beta-D-glucopyranoside, or nomilinic acid 17-beta-D-glucopyranoside. The 16 remaining animals were used as controls. These hamsters were treated five times per week, one day with mineral oil and the next with either water (Group I) or one of the 3.5% solutions of the limonoid glucosides (Groups II-IV). After 15 weeks (71 applications), the hamsters were killed. Multiple tumors were common in the animals treated with DMBA; however, the animals treated with limonin 17-beta-D-glucopyranoside exhibited a 55% decrease in average tumor burden. Further comparisons between Groups I and II showed that this reduction in tumor burden was mainly due to a decrease in tumor mass.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008647 Mesocricetus A genus in the order Rodentia and family Cricetidae. One species, Mesocricetus auratus or golden hamster is widely used in biomedical research. Hamsters, Golden,Hamsters, Golden Syrian,Hamsters, Syrian,Mesocricetus auratus,Syrian Golden Hamster,Syrian Hamster,Golden Hamster,Golden Hamster, Syrian,Golden Hamsters,Golden Syrian Hamsters,Hamster, Golden,Hamster, Syrian,Hamster, Syrian Golden,Syrian Hamsters
D009062 Mouth Neoplasms Tumors or cancer of the MOUTH. Cancer of Mouth,Mouth Cancer,Oral Cancer,Oral Neoplasms,Cancer of the Mouth,Neoplasms, Mouth,Neoplasms, Oral,Cancer, Mouth,Cancer, Oral,Cancers, Mouth,Cancers, Oral,Mouth Cancers,Mouth Neoplasm,Neoplasm, Mouth,Neoplasm, Oral,Oral Cancers,Oral Neoplasm
D002610 Cheek The part of the face that is below the eye and to the side of the nose and mouth. Bucca,Buccas,Cheeks
D005260 Female Females
D005960 Glucosides A GLYCOSIDE that is derived from GLUCOSE. Glucoside
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014315 Triterpenes A class of terpenes (the general formula C30H48) formed by the condensation of six isoprene units, equivalent to three terpene units. Triterpene,Triterpenoid,Triterpenoids
D036701 Limonins A group of degraded TRITERPENES in which the four terminal carbons of the C17 side chain have been removed, and the remaining portion often forming C17 furans. Limonoid,Limonoid Tetranortriterpene,Limonoid Tetranortriterpenes,Limonoids,Tetranortriterpene,Tetranortriterpenes,Tetranortriterpenoid,Tetranortriterpenoids,Tetranortriterpene, Limonoid

Related Publications

E G Miller, and A P Gonzales-Sanders, and A M Couvillon, and J M Wright, and S Hasegawa, and L K Lam
January 1987, European journal of cancer & clinical oncology,
E G Miller, and A P Gonzales-Sanders, and A M Couvillon, and J M Wright, and S Hasegawa, and L K Lam
June 1988, Oral surgery, oral medicine, and oral pathology,
E G Miller, and A P Gonzales-Sanders, and A M Couvillon, and J M Wright, and S Hasegawa, and L K Lam
July 1980, Oral surgery, oral medicine, and oral pathology,
E G Miller, and A P Gonzales-Sanders, and A M Couvillon, and J M Wright, and S Hasegawa, and L K Lam
January 1981, Carcinogenesis,
E G Miller, and A P Gonzales-Sanders, and A M Couvillon, and J M Wright, and S Hasegawa, and L K Lam
January 1995, Nutrition and cancer,
E G Miller, and A P Gonzales-Sanders, and A M Couvillon, and J M Wright, and S Hasegawa, and L K Lam
December 1966, Cancer research,
E G Miller, and A P Gonzales-Sanders, and A M Couvillon, and J M Wright, and S Hasegawa, and L K Lam
December 1978, Oral surgery, oral medicine, and oral pathology,
E G Miller, and A P Gonzales-Sanders, and A M Couvillon, and J M Wright, and S Hasegawa, and L K Lam
November 1982, Oral surgery, oral medicine, and oral pathology,
E G Miller, and A P Gonzales-Sanders, and A M Couvillon, and J M Wright, and S Hasegawa, and L K Lam
July 2000, Oral oncology,
E G Miller, and A P Gonzales-Sanders, and A M Couvillon, and J M Wright, and S Hasegawa, and L K Lam
January 2016, Methods in molecular biology (Clifton, N.J.),
Copied contents to your clipboard!